What does Shanghai Labway Clinical Laboratory Co., Ltd. do?

Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 301060.SZ's market cap?

Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) has a market capitalization of approximately $4.48 billion, as of August 28, 2026, based on the most recent share price and shares outstanding.

Does 301060.SZ pay a dividend?

Yes — Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) pays a dividend annually, with a trailing-twelve-month yield of 1.60%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

SHZ·Medical, Diagnostics & Research · Healthcare

¥11.24¥0.52−4.42%

Market cap¥4.48B·Market closed·Aug 28 6:01 AM UTC

Price Chart

¥11.24−¥0.52 (−4.42%)today

−38.48%CAGR −9.34%

Select date range

FromTo

Sep 13, 2021Sep 13, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)1.60%

Annual Dividend (FWD)¥0.18

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio48.8%

FCF Payout Ratio21.3%

Most Recent Dividend¥0.180

Ex-Dividend DateJun 8

Payment DateJun 8

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)−40.9%

EPS Growth (5Y)−26.9%

Next Earnings DateMar 31

Last Report DateApr 28

Reported vs Estimate¥0.09

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.28B

Net Income¥38.63M

Net Margin3.0%

Operating Cash Flow¥387.75M

Capital Expenditures¥51.46M

Free Cash Flow¥336.29M

Return on Equity2.5%

Return on Invested Capital1.6%

Net Cash¥647.20M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 301060.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 301060.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 301060.SZ and 80,000+ other tickers.

About Shanghai Labway Clinical Laboratory Co., Ltd.

Shanghai Labway Clinical Laboratory Co., Ltd. provides a dual service offering: comprehensive medical laboratory services and the distribution of in vitro diagnostic (IVD) products. Established in 1993, the company is headquartered in Shanghai, China.

CEO: Weixiong Zeng
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: SHZ
Employees: 1,245
Website: www.labway.cn

Peers

Peers Tab

300396.SZ

Dirui Industrial Co.,Ltd.

Cap

¥2.0B

300639.SZ

Guangdong Hybribio Biotech Co.,Ltd.

Cap

¥3.9B

300439.SZ

Medicalsystem Biotechnology Co., Ltd.

Cap

¥3.6B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 301060.SZ

What does Shanghai Labway Clinical Laboratory Co., Ltd. do?: Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 301060.SZ's market cap?: Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) has a market capitalization of approximately $4.48 billion, as of August 28, 2026, based on the most recent share price and shares outstanding.
Does 301060.SZ pay a dividend?: Yes — Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) pays a dividend annually, with a trailing-twelve-month yield of 1.60%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.